Eccogene
China - Shanghai
BiotechnologyFocus: Small Molecules
Eccogene is a life sciences company focused on Small Molecules.
Infectious DiseasesMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
AZD5004
Obesity or OverweightClinical Trials (1)
NCT06988553A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus
Phase 1ECC5004
Type 2 Diabetes MellitusClinical Trials (1)
NCT06293742ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
Phase 1Phase 1
Clinical Trials (1)
NCT05552274FTIH of ECC4703 in Healthy Volunteers
Phase 1ECC5004
Type 2 Diabetes MellitusClinical Trials (1)
NCT06268145ECC5004 RBA FE Study in Healthy Participants
Phase 1Placebo
Type 2 Diabetes MellitusClinical Trials (1)
NCT05654831FTIH of ECC5004 in Healthy and Diabetic Participants
Phase 1ECC4703 F0 formulation
Metabolic Dysfunction-Associated SteatohepatitisClinical Trials (1)
NCT07334080ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants
Phase 1Placebo
Nonalcoholic SteatohepatitisClinical Trials (1)
NCT05012423FTIH Study of ECC0509 in Healthy Volunteers
Phase 1Phase 2
Clinical Trials (1)
NCT07288138A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2019
Portfolio: 8 clinical trials